Cargando…

Reassessment of Pioglitazone for Alzheimer’s Disease

Alzheimer’s disease is a quintessential ‘unmet medical need’, accounting for ∼65% of progressive cognitive impairment among the elderly, and 700,000 deaths in the United States in 2020. In 2019, the cost of caring for Alzheimer’s sufferers was $244B, not including the emotional and physical toll on...

Descripción completa

Detalles Bibliográficos
Autores principales: Saunders, Ann M., Burns, Daniel K., Gottschalk, William Kirby
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243371/
https://www.ncbi.nlm.nih.gov/pubmed/34220427
http://dx.doi.org/10.3389/fnins.2021.666958